Sign up
Login
Friday 14th November 2014
13:45 Welcome and Introduction (D. Betticher, Fribourg/M. Ghielmini, Bellinzona)
How should double-hit lymphomas be treated?
14:00 Clinical case (L. de Leval / J.-P. Zurcher)
14:10 Clinical case (S. Dirnhofer / F. Krasniqi)
14:20 Lecture (P. Johnson, Southampton)
14:50 Open discussion
Is there anything like indolent Mantle Cell lymphoma?
15:00 Clinical case (L. de Leval / J.-P. Zurcher)
15:10 Clinical case (S. Dirnhofer / F. Krasniqi)
15:20 Lecture (M. Ghielmini, Bellinzona)
15:50 Open discussion
16:00 Coffee break
Has interim PET any clinical consequence?
16:30 Clinical case (L. de Leval / J.-P. Zurcher)
16:40 Clinical case (S. Dirnhofer / F. Krasniqi)
16:50 Lecture (M. Meignan, Creteil)
17:20 Open discussion
When should residual disease be irradiated?
17:30 Clinical case (L. de Leval / J.-P. Zurcher)
17:40 Clinical case (S. Dirnhofer / F. Krasniqi)
17:50 Lecture (L. Specht, Copenhagen)
18:20 Open discussion
18:30 Adjourn
Saturday 15th November 2014
Should BEACOPPesk still be used, and when?
08:00 Clinical case (L. de Leval / J.-P. Zurcher)
08:10 Clinical case (S. Dirnhofer / F. Krasniqi)
08:20 Lecture (A. Lohri, Basel)
08:50 Open discussion
What to do with antibiotic-resistant gastic MALT and non-gastic MALT cases?
09:00 Clinical case (L. de Leval / J.-P. Zurcher)
09:10 Clinical case (S. Dirnhofer / F. Krasniqi)
09:20 Lecture (E. Zucca, Bellinzona)
09:50 Open discussion
10:00 Coffee break
How should 17p- CLL be treated?
10:30 Clinical case (L. de Leval / J.-P. Zurcher)
10:40 Clinical case (S. Dirnhofer / F. Krasniqi)
10:50 Lecture (M. Gregor, Luzern)
11:20 Open discussion
Which are the new therapeutic agents and how will they enter clinical practice?
11:30 Clinical case (L. de Leval / J.-P. Zurcher)
11:40 Clinical case (S. Dirnhofer / F. Krasniqi)
11:50 Lecture (E. Zucca, Bellinzona)
12:20 Open discussion
12:30 Conclusions and evaluation
13:00 End